Scale AI 2026: Complete Funding Guide for Canadian AI Companies

Scale AI is the most under-utilized large grant in Canadian innovation funding. It is the country's national AI cluster — one of five Global Innovation Clusters — and it writes meaningful, non-dilutive cheques for AI commercialization projects. But it's also more selective than SR&ED, more structurally complex than IRAP, and built around a consortium model that catches a lot of first-time applicants off guard. This guide walks through how the program actually works, what it funds, where applications fail, and how Scale AI fits alongside the other tools in a Canadian AI company's funding stack.

What Scale AI is, and how it fits in Canadian AI funding

Scale AI is Canada's national AI cluster organization, headquartered in Montreal, with a mandate to "take AI out of the lab and into the real world." It was created in 2018 as one of five federal superclusters — an Innovation, Science and Economic Development Canada (ISED) initiative designed to concentrate co-investment around specific technology themes. The supercluster program has since been rebranded as Canada's Global Innovation Clusters, but the underlying funding mechanism is the same: federal money pooled with private contributions, deployed via the cluster to industry-led consortia.

That structural fact — that Scale AI is a private not-for-profit administering federal money rather than a CRA tax credit or a direct-from-government grant program — is the first thing to internalize. It changes how you apply, who you apply with, and how the funding flows. Where SR&ED is a retroactive tax credit you claim on your T2, and IRAP is a direct contribution administered by NRC, Scale AI is closer to a co-investment partnership: you bring a project plan and partners, they bring matching federal dollars and an investment director.

For Canadian AI companies, Scale AI sits at the top of the non-dilutive funding stack for one specific scenario: you have an AI product or solution that's past the prototype stage, you have at least one real customer or industry partner who wants to deploy it, and the work in front of you is commercialization rather than pure research. If that's the profile, no other Canadian program writes cheques in that size for that purpose.

The three funding streams

Scale AI organizes its funding into three streams. Most applicants are interested in the first — the industry-led Projects stream — but understanding all three helps you slot your initiative into the right vehicle.

Throughout the rest of this guide, when we say "Scale AI funding" without qualification, we mean Stream 1 — the industry-led Projects stream. That's where 80–90% of the program's dollars flow and where most operating AI companies will end up.

Project eligibility and consortium structure

The Projects stream is built around three eligibility tests: who you are, who you're working with, and what the project does. Miss any one of these and the application doesn't progress past the initial review.

1. Who you are

Scale AI funds Canadian-based organizations. There's no specific revenue floor or ceiling like CanExport's $300K–$100M band, but participants need to be properly incorporated in Canada, with the operational team and the AI work actually happening here. Multinationals with Canadian subsidiaries can participate, but the project work needs to land on Canadian soil with Canadian jobs and Canadian IP outcomes. The eligible participant types include:

• Solution Adopters — companies deploying AI to solve a real operational problem (typically the consortium lead)
• Product Companies — AI-native businesses providing the AI technology being deployed
• Service Providers — integrators, consulting firms, or specialists supporting the implementation
• Academia — universities and research centres providing technical depth or talent
• Consultants — in limited roles, typically not as the consortium lead

2. Who you're working with

This is the structural piece that surprises first-time applicants. Scale AI's Projects stream does not fund single companies. It funds consortia of two or more organizations, and at least one of those participants must be an SME with fewer than 500 full-time employees. The implicit logic: Scale AI wants to see AI moving from a vendor into a real customer's operations — the consortium structure forces that pairing into the application itself.

In practice, the most common consortium shape is:

• A larger Solution Adopter (the customer — often a mid-market or enterprise Canadian company in manufacturing, logistics, healthcare, retail, etc.)
• An AI Product Company (typically the SME — the vendor whose AI is being deployed)
• Sometimes a Service Provider, integrator, or academic partner rounding out the team

Scale AI helps with partner matching for members — the platform and networking events exist specifically to introduce vendors looking for solution adopters and vice versa — but the relationships in your consortium need to be real and operational, not partnerships of convenience built solely to satisfy the application form. Reviewers can tell the difference.

3. What the project does

The project itself has to be a credible AI commercialization or adoption initiative. The deliverable should be an AI product, capability, or deployment that creates measurable business impact in a value chain. Pure research, conceptual studies, and "explore whether AI could help us" engagements are not a good fit — that's IRAP-style or NSERC-style work. Scale AI's emphasis is incremental AI development with a clear path to deployment and revenue.

Eligible sectors are broad but oriented around real industry value chains:

• Consumer goods and retail
• Industrial goods and manufacturing
• Transport and logistics (one of Scale AI's largest concentrations)
• Healthcare
• Infrastructure and construction
• Other applied AI verticals on a case-by-case basis

Funding amounts and cost share

Here's where the practitioner-level numbers matter, and where we need to be precise about what Scale AI publishes versus what the typical funded project actually looks like.

Scale AI itself publishes its cost-share rate as "up to 40% of eligible expenses" on its current Projects page. In practice, the funded share that actually lands — once eligibility scrubs, ineligible cost categories, and consortium allocations are accounted for — tends to settle closer to one-third of total project costs. We use 33% as the planning anchor for Canadian AI companies modelling out a Scale AI budget, with the understanding that the headline rate is higher and the realized rate depends on the project's expense mix.

That math has implications for project sizing. A $1.5M consortium project at a one-third cost-share is roughly $500K of Scale AI contribution and $1M of consortium-side spend. The consortium covers its share in cash — this is not a credit, not a deferred liability, and not an in-kind valuation game. Each consortium member needs the working capital to fund its own portion of project activities and then recover the Scale AI share quarterly on a reimbursement basis. A vendor that can't carry several months of payroll on a project doesn't have a viable Scale AI strategy.

Eligible expenses

Scale AI's eligible expense categories for the Projects stream are broad and oriented around getting AI into production:

• Salaries, wages, and contract labour directly tied to project activities
• Equipment, software, and supplies purchased or rented for the project
• Critical services required to deliver the project (cloud compute, specialized data services, third-party APIs, etc.)
• Dissemination costs relevant to the project's success — conferences, demonstrations, knowledge transfer activities
• Capital expenditures directly linked to the project's technical objectives

This is materially broader than CanExport's eight tightly-defined expense categories, but the discipline cuts the other way: every claimed expense must tie back to specific approved project activities in the funding agreement, and reimbursement requires the standard contribution-program paper trail (invoices, proof of payment, time records). Audit posture matters.

Application flow and intake windows

Scale AI does not run discrete annual intake windows like CanExport does. Instead, it operates a rolling intake with weekly investment-director information sessions — typically Thursdays at 3:00 p.m. ET — where applicants present their concept, get feedback, and learn whether to proceed to formal application. This format is closer to a corporate development conversation than a government grant submission, which throws applicants who expect a portal-and-deadline experience.

A note on lead time: a serious Scale AI project usually has a 6–12 month runway between the first investment-director conversation and the funding agreement being signed. Companies that try to compress that — consortium-form, propose, and execute in 90 days — almost always stall at the consortium-alignment step. Industry partners take time to commit budget and sign letters.

How Scale AI projects differ from SR&ED claims

One of the most common misunderstandings we see at GovMoney is companies treating Scale AI and SR&ED as substitutes. They are not. They are different instruments funding different types of work at different points in time, and a well-structured AI company will often want both.

Put differently: SR&ED is what you claim when your engineers spent six months wrestling with a model architecture that didn't have a known solution. Scale AI is what you propose when your customer is willing to co-invest in deploying that model into their operations. The work is sequential more often than substitutable — the R&D happens, you claim SR&ED on it, and then the deployment happens with a Scale AI partner.

Stacking Scale AI with SR&ED and IRAP

Scale AI funding can be stacked with other federal and provincial support, subject to standard stacking rules. The most common combinations:

Scale AI + SR&ED

This is the most important interaction to get right. SR&ED treats government assistance as a reduction to qualified expenditures. In plain English: if Scale AI is paying for a portion of an engineer's salary on a project, the SR&ED-eligible portion of that engineer's time is reduced by the assistance received. You can't double-dip the same dollar of salary through both programs.

This doesn't mean you have to choose. It means you need to track time and expenses carefully and apportion correctly. Two practical approaches we use with clients:

• Separate workstreams. If your team is doing pure R&D (model development, uncertainty resolution) and commercialization work (deployment, integration, customer-facing engineering), separate the time tracking. The R&D portion claims SR&ED; the commercialization portion sits inside the Scale AI project.
• Net-of-assistance SR&ED. Where work genuinely overlaps, claim the SR&ED-eligible portion net of the Scale AI contribution received against it. The SR&ED credit is smaller, but you keep both programs intact and audit-defensible.

The wrong move is silence — not disclosing Scale AI assistance on the SR&ED claim. CRA cross-references government assistance information, and undisclosed cluster funding is a fast path to a reassessment.

Scale AI + IRAP

NRC IRAP and Scale AI are complementary but not identical. IRAP funds R&D and early commercialization at the firm level, typically through contribution agreements with an Industrial Technology Advisor. Scale AI funds consortium-based AI deployment. A common sequence: IRAP funds the late-stage R&D and product readiness work; once a customer is in place, the AI vendor and customer form a consortium and Scale AI funds the deployment phase. Same engineer, two phases of work, two programs. They co-exist because they're funding different stages of the same product journey.

Scale AI + provincial programs

Provincial AI funding (Ontario's Vector Institute initiatives, Quebec's IVADO and AI cluster programs, BC's Innovate BC, etc.) can stack with Scale AI subject to per-program rules and the standard federal–provincial stacking cap (typically 75% total government assistance across all sources for the same eligible costs). Disclosure is required in every direction. Scale AI's funding agreement requires you to declare other government assistance; the provincial agreements typically require the same. The 75% cap usually isn't a binding constraint at Scale AI's one-third cost-share, but it can become one if you layer multiple provincial sources on top.

Common reasons applications fail

Scale AI publishes selection criteria but does not publish detailed rejection statistics. From the applications we've observed and worked on, the pattern is consistent. Most rejected projects fail for one of these reasons:

• No real consortium — just a vendor with a willing letter-writer. Reviewers can tell the difference between a customer who's actually allocating budget, engineering time, and operational data to the project and one who has signed a letter of intent as a favour. If the Solution Adopter isn't materially co-investing, the consortium is a fig leaf.
• Project is pure research, not commercialization. "We will explore the application of large language models to claims processing" is a research proposal. Scale AI wants "We will deploy our existing claims-processing AI into Customer X's operations, integrating it with their two upstream systems and measuring cycle-time reduction over 12 months." The verb matters.
• Weak business impact case. Scale AI weights business impact at 20%. A proposal that can't articulate the dollar value of the AI deployment to the Solution Adopter — cost savings, revenue lift, throughput improvement, defect reduction — doesn't score.
• Budget that doesn't tie to activities. A budget line that says "$280,000 — AI development" with no further breakdown signals an underdeveloped proposal. Reviewers want to see who is doing what work, for how many hours, at what rate, with what deliverable.
• Wrong vehicle. Some applicants pitch the Projects stream when their initiative is actually a training engagement (Stream 3) or an accelerator program (Stream 2). The investment-director session is designed to catch this early; ignoring that feedback wastes everyone's time.
• Working capital mismatch. Scale AI reimburses quarterly. If a consortium SME doesn't have the runway to fund three to six months of project expenses before the first reimbursement lands, the project becomes unworkable mid-execution. Reviewers look at financial capacity.
• IP arrangements unresolved. When the AI is being developed or refined in collaboration with the Solution Adopter, IP ownership questions need to be answered in the proposal, not deferred. Unresolved IP is a red flag in cluster funding generally.

Is Scale AI right for your company?

Scale AI is a strong fit if you are a Canadian AI product company with a working solution, at least one identified customer or industry partner willing to be the Solution Adopter, a project scope in the $1M–$5M total budget range, and the operational and financial capacity to manage a multi-quarter consortium initiative. AI companies in logistics, manufacturing, healthcare, retail, and infrastructure verticals have historically been well-represented in the program's portfolio.

It's a poor fit, or outright premature, if you are pre-product (no deployable AI yet), if you have no customer relationships warm enough to support a real consortium, if your project is fundamentally R&D rather than deployment, if your total budget is well below $1M (the program's overhead doesn't make sense at smaller scales), or if you don't have the working capital to fund several months of project costs before the first reimbursement lands.

For companies in that earlier stage — pre-customer AI startups doing model development — the better non-dilutive stack is usually SR&ED for the R&D work, IRAP for late-stage product readiness, and a Scale AI conversation pencilled in for the deployment phase 12–18 months later.

Final thoughts

Scale AI is one of the most powerful non-dilutive tools available to Canadian AI companies — but only when the company is at the right stage and willing to operate inside the program's consortium structure. The cost-share is meaningful, the cheques are large enough to materially change a project's economics, and a well-executed Scale AI project tends to produce both a deployed AI capability and a Solution Adopter who becomes a long-term customer.

The selectivity is real, though, and the consortium-and-commercialization barriers catch a lot of first-time applicants. The most common pattern of failure isn't an unfundable project — it's a fundable project that wasn't ready when the company tried to apply: the customer wasn't actually committed, the budget wasn't structured, the IP wasn't resolved, or the consortium was a paper construct. Companies that treat the investment-director session as a real diagnostic conversation — rather than a procedural step — tend to come out of it with either a sharpened proposal or a clear understanding that they should come back in six months. Both outcomes are useful.

If your company is doing AI work in Canada, Scale AI should be one line on a broader funding stack that also includes SR&ED for the R&D portion, IRAP for product-readiness contributions, and provincial programs where they fit. Use our Grant Finder to compare Scale AI against SR&ED, IRAP, and provincial AI initiatives before deciding where to commit application time.